1. wolf3489
2. smimi6
1.smimi6 02/12/2018
Mizuho Securities initiates as a neutral, $28PT
2.wolf3489 02/12/2018
REGENXBIO Announces Completion of Dosing of Third Cohort in Phase I Clinical Trial of RGX-314 Gene Therapy for Wet AMD
3.smimi6 03/07/2018
Great volume too {Image}
4.smimi6 02/08/2018
Announces completion of dosing of third cohort in phase I clinical trial of RGX-314 Gene Therapy
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW